Effect of interleukins on UGT2B15 and UGT2B17 steroid uridine diphosphate-glucuronosyltransferase expression and activity in the LNCaP cell line

Endocrinology

Volumn 139, Issue 5, 1998, Pages 2375-2381

  Lévesque, Éric ^a   Beaulieu, Martin ^a   Guillemette, Chantal ^a   Hum, Dean W ^a   Bélanger, Alain ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLUCURONOSYLTRANSFERASE; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; INTERLEUKIN 6;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DNA TRANSFECTION; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

EID: 0031764262     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.5.6001     Document Type: Article

References (63)

1. Chen JQ, Ström A, Gustafsson JA, Morgan ET 1995 Suppression of the constitutive expression of cytochrome P-450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: Comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6. Mol Pharmacol 47:940-947
2. Monshower M, Witkamp RF, Nijmeijer SM, Van Amsterdam JG, Van Miert ASPAM 1996 Suppression of cytochrome P450- and UDP glucuronosyltransferase-dependent enzyme activities by proinflammatory cytokines and possible role of nitric oxide in primary cultures of pig hepatocytes. Toxicol Appl Pharmacol 137:237-244
3. Monshower M, Witkamp RF, Nijmeijer SM, Van Leengoed LAMG, Verheijden JHM, Van Miert ASJPAM 1995 Infection (actinobacillus pleuro-pneumoniae)-mediated suppression of oxidative hepatic drug metabolism and cytochrome P4503A mRNA levels in pigs. Drug Metab Disp 23:44-47
4. Renton KW, Knickle LC 1990 Regulation of hepatic cytochrome P-450 during infectious disease. Can J Physiol Pharmacol 68:771-781
5. Renton KW 1981 Depression of hepatic cytochrome P-450-dependent mixed function oxidases during infection with encephalomyocarditis virus. Biochem Pharmacol 30:2333-2336
6. Renton KW 1986 Factors affecting drug biotransformation. Clin Biochem 19:72-75
7. Ferrari L, Herber R, Batt AM, Siest G 1993 Differential effects of human recombinant interleukin-1β and dexamethasone on hepatic drug-metabolizing enzymes in male and female rats. Biochem Pharmacol 45:2269-2277
8. Morgan ET, Thomas R, Swanson R, Vales T, Hwang J, Wright K 1994 Selective suppression of cytochrome P-450IIB in cultured rat hepatocytes. Biochim Biophys Res Commun 178:475-483
9. Wright K, Morgan ET 1991 Regulation of cytochrome P450IIC12 expression by interleukin-1α, interleukin-6, and dexamethasone. Mol Pharmacol 39:468-474
10. Morgan ET 1989 Suppression of constitutive cytochrome P-450 gene expression in livers of rats undergoing an acute phase response to endotoxin. Mol Pharmacol 36:699-707
11. Wright K, Morgan ET 1990 Transcriptionnal and post-transcriptionnal suppression of P450IIC11 and P450IIC12 by inflammation. FEBS Lett 271:59-61
12. Dutton GJ 1980 Glucuronidation of Drugs and Other Compounds. CRC Press, Boca Raton
13. Burchell B, Coughtrie MW 1989 UDP-glucuronosyltransferases. Pharmacol Ther 43:261-289
14. Burchell B, Coughtrie MWH, Jansen PLM 1994 Function and regulation of UDP-glucuronosyltransferase genes in health and liver disease: report of the Seventh International Workshop on Glucuronidation, September 1993, Pitlochry, Scotland. Hepatology 20:1622-1630
15. Mulder GJ 1992 Glucuronidation and its role in regulation of biological activity of drugs. Annu Rev Pharmacol Toxicol 32:25-49
16. Burchell B, Nebert DW, Nelson DR, Bock KW, Iyanagi T, Jansen PLM, Lancet D, Mulder GJ, Chowdhury JR, Siest G, Tephly TR, Mackenzie PI 1991 The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence. DNA Cell Biol 10:487-94
17. Guillemette C, Lévesque É, Beaulieu M, Turgeon D, Hum WD, Bélanger A 1997 Differential regulation of two UDP-glucuronosyltransferases, UGT2B15 and UGT2B17, in human prostate LNCaP cells. Endocrinology 138:2998-3005
18. Beaulieu M, Lévesque É, Hum DW, Bélanger A 1996 Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids. J Biol Chem 271:22855-22862
19. Bélanger A, Brochu M, Cliche J 1986 Levels of plasma steroid glucuronides in intact and castrated men with prostatic cancer. J Clin Endocrinol Metab 62:812-815
20. Bélanger A, Couture J, Caron S, Roy R 1990 Determination of non-conjugated and conjugated steroid levels in plasma and prostate after separation on C-18 columns. Ann NY Acad Sci 595:251-259
21. Bélanger G, Beaulieu M, Marcotte B, Lévesque É, Guillemette C, Hum DW, Bélanger A 1995 Expression of transcripts encoding steroid UDP-glucuronosyltransferases in human prostate hyperplastic tissue and the LNCaP cell line. Mol Cell Endocrinol 113:165-173
22. Chen F, Ritter JK, Wang MG, Mcbride OW, Lubet RA, Owens IS 1993 Characterization of a cloned human dihydrotestosterone/androstanediol UDP-glucuronosyltransferase and its comparison to other steroid isoforms Biochemistry 32:10648-10657
23. Lévesque E, Beaulieu M, Green MD, Tephly TR, Bélanger A, Hum DW 1997 Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 7:317-325
24. Chang SM, Chung LWK 1989 Interaction between prostatic fibroblast and epithelial cells in culture: role of androgen. Endocrinology 125:2719-2727
25. Steiner MS 1993 Role of peptide growth factors in the prostate: a review. Urology 42:99-110
26. Degeorges A, Tatoud R, Fauvel-Lefeve F, Podgorniak MP, Millot G, De Cremoux P, Calvo F 1996 Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6. Int J Cancer 68:207-214
27. Savarese DMF, Savarese TM, Valinski H, Quesenberry PJ 1995 Expression of cytokines, colony-stimulating factors and their receptors in human prostatic carcinoma cell lines. Proc Am Assoc Cancer Res 36:642
28. Habib FK, Chislom GD 1991 The role of growth factors in the human prostate. Scand J Urol Nephrol [Suppl] 138:53-58
29. Blais Y, Carrière MC, Simard J, Labrie F, Regulation of 17β-HSD activity by IL-4 and IL-6 in ZR-75-1 human breast cancer cells. 76th Annual Meeting of The Endocrine Society, Anaheim CA, 1994, p 1294 (Abstract)
30. Reed MJ, Purohit A, Duncan LJ, Singh A, Roberts CJ, Williams GJ, Potter BVL 1995 The role of cytokines and sulphatase inhibitors in regulating oestrogen synthesis in breast tumors. J Steroid Biochem Mol Biol 53:413-420
31. Reed MJ, Coldham NG, Patel SR, Ghilchick MW, James VHT 1992 Interleukin-1 and interleukin-6 in breast cyst fluid: their role in regulating aromatase activity in breast cancer cells J Endocrinol 132:R5-R8
32. Pottratz ST, Bellido T, Mocharla H, Crabb D, Manolagas SC 1994 17β-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest 93:944-950
33. Lee SW, Tsou AP, Chan H, Thomas J, Petrie K, Eugui EM, Allison AC 1988 Glucocorticoids selectively inhibit the transcription of the interleukin 1β gene and decrease the stability of interleukin 1β mRNA. Proc Natl Acad Sci USA 85:1204-1208
34. Debinski W, Puri RK, Kreitman RJ, Pastan I 1993 A wide range of human cancer cells express interleukin 4 (1L4) receptors that can be targeted with chimeric toxin composed of 1L4 and pseudomonas exotoxin. J Biol Chem 268:14065-14070
35. Hsieh TC, Chiao JW 1995 Growth modulation of human prostatic cancer cells by interleukin-1 and interleukin-1 receptor antagonist. Cancer Lett 95:119-123
36. Serve H, Steinhauser G, Oberberg D, Flegel WA, Northoff H, Berdel WE 1991 Studies on the interaction between interleukin 6 and malignant nonhematopoietic cell lines. Cancer Res 51:3862-3866
37. Siegall CB, Schwab G, Nordan RP, Fitzgerald DJ, Pastan I 1990 Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma. Cancer Res 50:7786-7788
38. Miki S, Iwano M, Miki Y, Yamamoto M, Tang B, Yokokawa K, Sonoda T, Hirano T, Kishimoto T 1989 Interleukin-6 (1L-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 250:607-610
39. Okamoto M, Lee C, Oyasu R 1996 Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res 141-146
40. Guillemette C, Hum DW, Bélanger A 1996 Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line. Endocrinology 137:2872-2879
41. Lévesque É, Beaulieu M, Guillemette C, Hum DW, Bélanger A, Effect of fibroblastic growth factors (FGF) on steroid UDP-glucuronosyltransferase expression and activity in the LNCaP cell line. J Steroid Biochem Mol Biol, in press
42. Beaulieu M, Lévesque É, Tchernof A, Beatty B, Bélanger A, Hum DW 1997 Chromosomal localization, structure and regulation of the UGT2B17 gene, encoding a steroid metabolizing enzyme. DNA Cell Biol 16:1143-1155
43. Guillemette C, Bélanger A 1995 Glucuronosyltransferase activity in human cancer cell line LNCaP. Mol Cell Endocrinol 107:131-139
44. Fiszer-Szafarz B, Szafarz D, Guevara A 1981 A general, fast, and sensitive micromethod for DNA determination: application to rat and mouse liver, rat hepatoma, human leukocytes, chicken fibroblasts, and yeast cells. Anal Biochem 110:165-170
45. Kramer C 1956 Extension of multiple range tests to group means with unique number of replications. Biometrics 12:307-310
46. Rodbard D, Lewald JE 1970 Computer analysis of radioligand assay and radioimmunoassay data. In: 2nd Karolina Symposium on Research Methods in Reproduvtive Endocrinology. Bogtryklereit Forum, Copenhagen, pp 79-103
47. Goldman D, Yawetz A 1990 The interference of arochlor 1254 with progesterone metabolism in guinea pig adrenal and testes. J Biochem Toxicol 5:99-107
48. Sambrook J, Fritsh EF, Maniatis T 1982 Molecular Cloning: A Laboratory Manual, ed 2. Cold Spring Harbor Laboratory, Cold Spring Harbor
49. Blais Y, Sugimoto K, Carriere MC, Haagensen DE, Labrie F, Simard J 1995 Interleukin-6 inhibits the potent stimulatory action of androgens, glucocorticoids and interleukn-1α on apolipoprotein D and GCDFP-15 expression in human breast cancer cells. Int J Cancer 62:732-737
50. Keller ET, Chang C, Ershler WB 1996 Inhibition of NFκB activity through maintenance of IkB levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter. J Biol Chem 271:26267-26275
51. Carter DB, Deibel MR, Dunn JCJ, Tomich CSC, Laborde AL, Slightom JL, Berger AE, Bienkowski MJ, Sun FF, McEwan RN, Harris PK, Yem AW, Waszak GA, Chosay JG, Sieu LC, Hardee HA, Zurcher-Neely HA, Reardon IM, Heinrikson RL, Truesdell SE, Shelly JA, Eessalu TE, Taylor BM, Tracey DE 1990 Purification, cloning, expression, and biological activity of an interleukin-1 receptor antagonist protein. Nature 344:633-637
52. Abdel-Razzak Z, Loyer P, Fautrel A, Gautier JC, Corcos L, Turlin B, Beaume P, Guillouzo A 1993 Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 44:707-715
53. Watanabe S, Arai KI 1996 Roles of the JAK/STAT system in signal transduction via cytokines receptors. Curr Opin Genet Dev 6:587-596
54. Kishimoto T, Taga T, Akira S 1994 Cytokine signal transduction. Cell 76:253-262
55. Mui ALF, Miyajima A 1994 Cytokine receptors signal transduction. Prog Growth Factors Res 5:15-35
56. Seger R, Krebs EG 1995 The MAPK signalling cascade. FASEB J 9:726-735
57. Li S, Sedivy JM 1993 Raf-1 protein kinase activates the NF-κB transcription factor by dissociating the cytoplasmic NF-κB-1κB complex. Proc Natl Acad Sci USA 90:9247-9251
58. Takimoto M, Quinn JP, Farina R, Staudt L, Levens D 1989 Fos/Jun and octamer-binding protein interact with a common site in a negative element of the human c-myc gene. J Biol Chem 264:8992-8999
59. Leclair KP, Blanar MA, Sharp PA 1992 The p50 subunit of NFκB associates with the NF-1L6 transcription factor. Proc Natl Acad Sci USA 89:8145-8149
60. Stein B, Baldwin ASJ 1993 Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperatively between C/EBP and NFκB. Mol Cell Biol 13:7191-7198
61. Finco TS, Baldwin ASJ 1993 κB site-dependent induction of gene expression by diverse inducers of nuclear factor κB requires raf-1. J Biol Chem 268:17676-17679
62. Stein B, Cogswell PC, Baldwin ASJ 1993 Functional and physical associations between NF-κB and C/EBP family members: a rel domain-bZIP interaction. Mol Cell Biol 13:3964-3974
63. Stein B, Baldwin ASJ, Ballard DW, Greene WC, Angel P, Herrlich P 1993 Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J 12:3879-3891